Luis Borges
SVP, Research, FIVE PRIME THERAPEUTICS, INC.
Companies
- Metagenomi Therapeutics, Inc.Chief Scientific Officer Feb 8, 2024 to Apr 3, 20241
- Century Therapeutics (United States)Chief Scientific Officer Jun 17, 2021 to Apr 5, 20232
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Century Therapeutics (United States) IPSC256,535 shares3$384.8K at $1.50Apr 3, 2023
- Metagenomi Therapeutics, Inc. MGX69,316 shares4$58.6K at $0.84Apr 1, 2024
As of each latest filing. The line shows shares held over time.
Recent filings
- Apr 1, 2024Granted 69,316 shares of Metagenomi Therapeutics, Inc.4
- Apr 3, 2023Exercised options 7,452 shares at $1.03 of Century Therapeutics (United States)3
- Mar 23, 2023Sold 15,597 shares at $3.55 of Century Therapeutics (United States)5
- Mar 23, 2023Exercised options 220,930 shares at $1.03 of Century Therapeutics (United States)5
- Mar 22, 2023Sold 65,698 shares at $3.72 of Century Therapeutics (United States)5
- Mar 22, 2023Exercised options 65,698 shares at $1.03 of Century Therapeutics (United States)5
- Mar 21, 2023Sold 63,616 shares at $3.77 of Century Therapeutics (United States)5
- Mar 21, 2023Exercised options 63,616 shares at $1.03 of Century Therapeutics (United States)5
- Feb 2, 2023Granted 21,875 shares of Century Therapeutics (United States)6
- Feb 2, 2023Granted 21,875 shares of Century Therapeutics (United States)6
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5SEC EDGARForm 4 filed Mar 23, 2023
- 6SEC EDGARForm 4 filed Feb 6, 2023